Semaglutide shown to be effective for weight loss in multicenter, one-year real-world study

New research presented at this year’s European Congress on Obesity (ECO2023, Dublin, 17-20 May) shows that the obesity drug semaglutide is effective for weight loss in a multicenter, 1-year-long real-world study. The study is by Dr. Andres Acosta and Dr. Wissam Ghusn, Precision Medicine for Obesity Program at the Mayo Clinic, Rochester, MN, U.S. and colleagues.

This article was originally published on

You may also be interested in:

Read More:

Lawyers Lookup